Decrease in RAS activity by attenuating angiotensin II levels (ATII) which abolishes its detrimental effects such as vasoconstriction (VC), fibrosis, hypertension (HTN) and inflammation;. The gene discussed is AGT; the disease is hypertensive disorder.